Pharmacovigilance & Regulatory Affairs Consulting in China

PV Solutions Limited provides consulting services to International pharmaceutical companies on pharmacovigilance and regulatory affairs in China.

Bilingual GVP and GCP audit readiness and local pharmacovigilance representation delivered by experts with decades of China regulatory experience.

Decades of compliance precision

20+

Years of local NMPA experience

100%

Audit readiness success rate

25+

Serve countries of pharma companies

Our Capabilities

Comprehensive risk mitigation

We bridge the gap between global pharmaceutical standards and local Chinese regulatory expectations.

China GVP/GCP Inspection & Audit

PV Strategy & Operations

Regulatory Intelligence

Meticulous pre-inspection audits and mock inspections designed to align your global protocols with local Chinese regulatory requirements.

Full-lifecycle pharmacovigilance system establishment, local RPPV/QPPV assignment, PSUR/PBRER, annual report, system files, and post-market surveillance strategies.

Real-time monitoring of NMPA policy shifts, providing actionable insights to keep your compliance framework ahead of changes.

Contact

We'd love to hear from you. Whether you're planning market entry in China, conducting a mock GCP inspection/GVP audit, or need regulatory guidance, reach out to PV Solutions Limited to discuss your project.

Email

info@chinapvsolutions.com